Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Our obesity medicine doctor will tell you honestly if youre a good fit
According to FDA labeling, no dose adjustment is required for patients with renal impairment, including those with end-stage renal disease (ESRD)
If there is any question about the pen's structural integrity, it is safer to obtain a replacement than to risk administering compromised medication
Earliest approval decision: mid-2027
For weight loss prescriptions, some primary care doctors prescribe freely while others prefer to refer to specialists
Retatrutide and cagrilintide Combining cagrilintide with retatrutide is gaining interest for enhanced weight loss
US$ 26.82
US$ 20.46
US$ 24.98
US$ 27.39
US$ 24.70
US$ 21.07
US$ 28.34
US$ 26.32
